CRISPR gene editing market share projections by world region 2019 vs 2030

Published by
Matej Mikulic,
Sep 20, 2021
This statistic depicts the projected distribution of the CRISPR gene editing market globally in 2019 and a forecast for 2030, by world region. North America's market share is expected to decrease from nearly 41 percent in 2019 to some 35 percent in 2030. CRISPR stands for "clustered regularly interspaced short palindromic repeats" and is often referred to as 'genetic scissors'.

CRISPR gene editing market share worldwide in 2019 and a forecast for 2030, by region

© Statista 2024
Download
Show detailed source information?
Register for free
Already a member?
Log in
Source

Use Ask Statista Research Service

In cooperation with
Release date

May 2021

Region

Worldwide

Survey time period

as of 2021

Supplementary notes

Percentage points exceeding 100 percent are probably due to rounding.

Citation formats
Access all statistics starting from $2,388 USD yearly *

* For commercial use only

Basic Account

For single users
$0 USD
Always free
Access limited to Free Statistics. Premium Statistics are not included.
  • Free Statistics
Based on your interests

Starter Account

For single users
$199 USD
per month, billed annually 1
Buy now
  • Free Statistics
  • Premium Statistics

    • The statistic on this page is a Premium Statistic and is included in this account.

Professional Account

For teams of up to 5 people
$959 USD
per month, billed annually 1
Buy now
  • Free + Premium Statistics
  • Reports
  • Market Insights

1 All prices do not include sales tax. The account requires an annual contract and will renew after one year to the regular list price.

Compare accounts

Statistics on " Medical biotech industry "

The most important statistics
The most important statistics
The most important statistics
The most important statistics
The most important statistics
The most important statistics
The most important statistics

Other statistics that may interest you Medical biotech industry

Global overview

7

U.S. and European landscape

6

Focus: U.S. companies

8

Research & development

6

Products

5

Funding/M&A/IPOs

6

Focus: RNA/mRNA

4

Further related statistics

10

Further Content: You might find this interesting as well

Statistics

Topics

CRISPR genome editingGlobal pharmaceutical industryBiotech drugsGenetically modified cropsAgriculture in the U.S.
All features, all contents, at all times: Learn more about our professional solutions.

* For commercial use only

Basic Account

For single users
$0 USD
Always free
Access limited to Free Statistics. Premium Statistics are not included.
  • Free Statistics
Based on your interests

Starter Account

For single users
$199 USD
per month, billed annually 1
Buy now
  • Free Statistics
  • Premium Statistics

    • The statistic on this page is a Premium Statistic and is included in this account.

Professional Account

For teams of up to 5 people
$959 USD
per month, billed annually 1
Buy now
  • Free + Premium Statistics
  • Reports
  • Market Insights

1 All prices do not include sales tax. The account requires an annual contract and will renew after one year to the regular list price.

Compare accounts
Learn more about how Statista can support your business.